company background image
8YY logo

Biolidics Catalist:8YY Stock Report

Last Price

S$0.012

Market Cap

S$8.9m

7D

0%

1Y

-20.0%

Updated

27 Mar, 2024

Data

Company Financials

8YY Stock Overview

Biolidics Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions.

8YY fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Biolidics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Biolidics
Historical stock prices
Current Share PriceS$0.012
52 Week HighS$0.022
52 Week LowS$0.01
Beta0.71
1 Month Change-7.69%
3 Month Change-7.69%
1 Year Change-20.00%
3 Year Change-95.71%
5 Year Change-96.07%
Change since IPO-94.89%

Recent News & Updates

Recent updates

Shareholder Returns

8YYSG Medical EquipmentSG Market
7D0%-3.5%1.9%
1Y-20.0%-6.4%-4.4%

Return vs Industry: 8YY underperformed the SG Medical Equipment industry which returned -5.5% over the past year.

Return vs Market: 8YY underperformed the SG Market which returned -4.4% over the past year.

Price Volatility

Is 8YY's price volatile compared to industry and market?
8YY volatility
8YY Average Weekly Movement13.0%
Medical Equipment Industry Average Movement6.4%
Market Average Movement4.8%
10% most volatile stocks in SG Market14.1%
10% least volatile stocks in SG Market2.2%

Stable Share Price: 8YY's share price has been volatile over the past 3 months.

Volatility Over Time: 8YY's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of SG stocks.

About the Company

FoundedEmployeesCEOWebsite
200930STY Songhttps://www.biolidics.com

Biolidics Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions. The company operates through Cancer, Infectious Diseases, and Laboratory Services segments. It provides Covid-19 PCR testing kits.

Biolidics Limited Fundamentals Summary

How do Biolidics's earnings and revenue compare to its market cap?
8YY fundamental statistics
Market capS$8.94m
Earnings (TTM)-S$2.49m
Revenue (TTM)S$1.36m

6.6x

P/S Ratio

-3.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8YY income statement (TTM)
RevenueS$1.36m
Cost of RevenueS$749.00k
Gross ProfitS$612.00k
Other ExpensesS$3.10m
Earnings-S$2.49m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.0033
Gross Margin44.97%
Net Profit Margin-182.81%
Debt/Equity Ratio-85.1%

How did 8YY perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.